DiaMedica Therapeutics Inc.
US ˙ NasdaqCM ˙ CA25253X2077

SecurityDMAC / DiaMedica Therapeutics Inc.
InstitutionVanguard Group Inc
Latest Disclosed Ownership723,120 shares
Latest Disclosed Value $ 5,756,035
Vanguard Group Inc reports 8.81% increase in ownership of DMAC / DiaMedica Therapeutics Inc.

On January 29, 2026 - Vanguard Group Inc filed a 13F-HR form disclosing ownership of 723,120 shares of DiaMedica Therapeutics Inc. (US:DMAC) valued at $5,756,035 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 7, 2025 disclosing 664,575 shares of DiaMedica Therapeutics Inc.. This represents a change in shares of 8.81% during the quarter. The current value of the position is $4,223,021 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-01-29 2025-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 723,120 58,545 8.81 5,756 26.09 0.0001
2025-11-07 2025-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 664,575 -870,479 -56.71 4,566 -23.74 0.0001
2025-08-11 2025-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,535,054 183,587 13.58 5,987 16.87 0.0001
2025-05-09 2025-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,351,467 109,360 8.80 5,122 -24.05 0.0001
2025-02-11 2024-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,242,107 193,078 18.41 6,745 53.45 0.0001
2024-11-13 2024-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,049,029 31,627 3.11 4,395 46.45 0.0001
2024-08-13 2024-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,017,402 3,880 0.38 3,001 6.91 0.0001
2024-05-10 2024-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 1,013,522 211,351 26.35 2,807 23.22 0.0001
2024-03-11 2023-12-31 13F/A-1 DIAMEDICA THERAPEUTICS COM NEW 25253X207 802,171 13,382 1.70 2,278 11.94 0.0000
2024-02-14 2023-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 802,171 13,382 2,278 0.0000
2023-12-18 2023-09-30 13F/A-1 DIAMEDICA THERAPEUTICS COM NEW 25253X207 788,789 5,800 0.74 2,035 -39.83 0.0000
2023-11-14 2023-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 788,789 5,800 2,035 0.0000
2023-08-14 2023-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,989 0 0.00 3,383 182.54 0.0001
2023-07-14 2023-03-31 13F/A-1 DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,989 0 0.00 1,198 -3.23 0.0000
2023-05-15 2023-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,989 0 1,198 0.0000
2023-02-10 2022-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,989 349 0.04 1,237 27.39 0.0000
2022-11-14 2022-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,640 0 0.00 971 -38.58 0.0000
2022-08-12 2022-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,640 0 0.00 1,581 -19.17 0.0000
2022-05-13 2022-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 782,640 -3,912 -0.50 1,956 -33.33 0.0000
2022-02-14 2021-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 786,552 -984 -0.12 2,934 -7.09 0.0001
2021-11-12 2021-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 787,536 1,270 0.16 3,158 -9.75 0.0001
2021-08-13 2021-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 786,266 -60,047 -7.10 3,499 -54.82 0.0001
2021-05-14 2021-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 846,313 66,415 8.52 7,744 -2.07 0.0002
2021-02-12 2020-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 779,898 438,054 128.14 7,908 445.76 0.0002
2020-11-16 2020-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 341,844 100,027 41.36 1,449 -13.54 0.0000
2020-08-14 2020-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 241,817 -123 -0.05 1,676 147.56 0.0001
2020-05-15 2020-03-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 241,940 160,885 198.49 677 72.26 0.0000
2020-02-14 2019-12-31 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 81,055 0 0.00 393 136.75 0.0000
2019-11-14 2019-09-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 81,055 46,817 136.74 166 -2.35 0.0000
2019-08-14 2019-06-30 13F DIAMEDICA THERAPEUTICS COM NEW 25253X207 34,238 34,238 170 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.